HIV/AIDS Clinical Trials

Find HIV/AIDS Clinical Trials Near You

Site-randomized Trial of a Novel Social Network Recruitment Intervention to Locate More Undiagnosed Positive Cases of HIV, Increase HIV Testing Among Men, and Reduce HIV-related Stigma in South Africa (E-SNRHT South Africa)

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

In South Africa's large generalized HIV epidemic, male-to-female transmission comprises a large proportion of transmission events, but men are much less likely to seek HIV testing, and disproportionately remain undiagnosed. HIV-related stigma is a key barrier to recruiting men to HIV testing in South Africa, as they report feeling blamed by their partners and communities for HIV transmission. This barrier must be addressed to increase testing among men and other testing-avoidant people in order to locate hard-to-reach undiagnosed cases and make progress towards 95-95-95 goals. Peer recruitment via social networks is an effective mechanism for promoting HIV testing, because people seek health information from peers, and peers influence health behavior norms within networks. However, standard risk network recruitment is limited in that: 1) recruiting one's own risk partners can trigger stigma and blame for HIV; and 2) it excludes people who have not engaged in HIV risk behavior recently and/or who no longer have contact with their risk partners. The Investigative Team for the present study developed an expanded social network recruitment to HIV testing (E-SNRHT) intervention to address these limitations and reduce stigma as a barrier to testing. E-SNRHT asks seeds (i.e., initial participants) who have been newly diagnosed with HIV (NDH) to recruit their expanded social network members (i.e., anyone they know) who they think could benefit from HIV testing or could have an undiagnosed HIV infection, tests these network members, and refers them to ART (if positive) or follow-up testing (if negative). By asking participants to recruit non-risk partners, E-SNRHT is designed to increase their comfort and likelihood of recruiting others, especially those who have avoided testing due to stigma. The Investigative Team's two previous pilot studies of E-SNRHT found that it recruits men to HIV testing at much higher rates than standard risk network recruitment; locates people with newly diagnosed HIV (PNDH; i.e., people with previously undiagnosed HIV infection) at a much higher rate per seed than standard risk network recruitment; and recruits people who have not tested in years, have never tested, and/or have not engaged in HIV risk behavior recently but have undiagnosed HIV infection. These pilot studies also found that E-SNRHT reduces HIV-related stigma and increases HIV-related social support among networks; and that 76% of E-SNRHT participants who were NDH started ART within 10 weeks. As participants recruit each other, their discussions help to normalize talking about HIV, thereby improving levels of stigma and support, which in turn should increase HIV service use and improve HIV care cascade outcomes. The present study will conduct a site-randomized trial of E-SNRHT, with 32 Department of Health clinics in KwaZulu-Natal, South Africa serving as sites. This study will compare E-SNRHT clinics to business-as-usual control clinics on: their rates of recruiting men to testing (Aim 1a) and locating PNDH (1b); participants' reports of HIV-related stigma and social support (Aim 2a); and treatment cascade outcomes (2b). Implementation science methods and qualitative methods will also be used to develop best practices (Aim 3) for future scale-up in South Africa and adaptation to other settings.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• Has study recruitment coupon (from clinic or from intervention arm participant)

• Is ≥ 18 years old

• Is able to be interviewed in English or isiZulu

• Is able to give informed consent

• Resides in the Msunduzi region

Locations
Other Locations
South Africa
Centre for Community-based Research, Human Sciences Research Council
RECRUITING
Pietermaritzburg
Contact Information
Primary
Leslie D. Williams, Ph.D.
lesliedw@uic.edu
312-996-8820
Backup
Alastair van Heerden, Ph.D.
alastair.vanheerden@wits.ac.za
Time Frame
Start Date: 2025-09-30
Estimated Completion Date: 2027-12-01
Participants
Target number of participants: 2480
Treatments
Experimental: E-SNRHT Intervention Arm
The E-SNRHT intervention arm will recruit people newly diagnosed with HIV as seeds from clinics randomly assigned to the intervention condition, briefly remind them of HIV transmission risks and how HIV spreads through networks, and ask them to recruit people in their expanded social networks (i.e., anyone they know) who they think might benefit from being tested for HIV, whether or not they have engaged in any HIV risk behaviors together. Thus, E-SNRHT aims to broaden the reach of HIV testing to people who are reluctant to participate in risk partner recruitment. Network members recruited by a seed will also be asked to recruit additional people they know using the same education and recruitment instructions provided to seeds. All network members will be tested for HIV and provided with pre- and post-test counseling, all participants diagnosed with HIV will be referred to care, and all participants who test negative for HIV will be referred to 3-month follow-up HIV testing.
No_intervention: Control Arm
The control arm consists of usual standard of care HIV testing and treatment at DoH clinics. In this arm, people newly diagnosed with HIV at clinics randomly assigned to the control condition will be recruited as control arm participants. They will be recruited and interviewed, and their HIV viral load will be measured. They will be encouraged to follow up with the clinic at which they were diagnosed for usual standard HIV care.
Related Therapeutic Areas
Sponsors
Collaborators: NYU Langone Health, National Institute of Mental Health (NIMH), Human Sciences Research Council
Leads: University of Illinois at Chicago

This content was sourced from clinicaltrials.gov